Acuamark Diagnostics

New York, United States

Acuamark develops technology that allows for highly accurate screening of blood to detect cancer markers at early cancer stages.

$11.6M raised

Apr 2022

Series A

Biotechnology Health Care Information Technology

Top Investors

1289 Capital Claudio Del Vecchio

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Acuamark Diagnostics

How much funding has Acuamark Diagnostics raised?

Acuamark Diagnostics has raised $11.6M in total funding. The most recent round was Series A. The last funding was announced in April 2022.

Who are Acuamark Diagnostics's investors?

Acuamark Diagnostics's investors include 1289 Capital, Claudio Del Vecchio.

Where is Acuamark Diagnostics headquartered?

Acuamark Diagnostics is headquartered in New York, United States.

What does Acuamark Diagnostics do?

Acuamark develops technology that allows for highly accurate screening of blood to detect cancer markers at early cancer stages.

What stage is Acuamark Diagnostics at?

Acuamark Diagnostics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 6, 2022.

MLA

"Acuamark Diagnostics — Funding & Investors." VCBacked, April 6, 2022, https://www.vcbacked.co/company/acuamark-diagnostics. Accessed July 6, 2026.

APA

VCBacked. (2022). Acuamark Diagnostics — Funding & Investors. Retrieved July 6, 2026, from https://www.vcbacked.co/company/acuamark-diagnostics

Wikipedia (cite web)

{{cite web |title=Acuamark Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/acuamark-diagnostics |website=VCBacked |access-date=July 6, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 6, 2022.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K